| Name | Title | Contact Details |
|---|
POLYVANTIS is a global, multi-material player with some of the most coveted and iconic brands in the industry – such as PLEXIGLAS® and ACRYLITE® for polymethylmethacrylate semi-finished products and LEXAN™ for polycarbonate sheets and films. With 1,500 employees and 15 production sites worldwide, POLYVANTIS offers unmatched global capabilities, providing customers with innovative solutions in sheets and films for the building and construction, electrical and electronics, automotive, air and rail, healthcare and security, and lighting and signage markets.
FABCON Design and Engineering (Pvt.) Ltd. is a multidisciplinary EPC Management Company, engaged in engineering, manufacturing and construction in the field of civil, mechanical, electrical and automation projects. Our primarily serving industries includes; • Oil and Gas Exploration • Refineries • Petrochemicals • OMC Plants • LPG Plants • Power Plants • Fertilizers Industry • Cement Industry • Sugar Industry • Textile Industry • Food and Beverages Industry • Paper and Pulp Industry • Commercial Infrastructure Projects • Government Infrastructure Development Sector • Defence Infrastructure Development Sector
Headquartered in Los Angeles, California, Manufacturers Bank is a wholly owned subsidiary of SMBC Americas Holding, Inc., a member of SMBC Group. For over 60 years, the Commercial Bank division of Manufacturers Bank has been serving middle-market and corporate businesses by providing sophisticated solutions and expertise with the personal touch of a community bank. The Commercial Bank division serves the specialized needs of middle-market and corporate businesses, franchise finance including quick service restaurants, manufacturers, wholesalers, distributors, importers, exporters, and service companies. We offer a comprehensive suite of credit, deposit and treasury management solutions including foreign exchange and trade finance. The Commercial Bank has offices in Los Angeles, Beverly Hills, Brea, Encino, Glendale, Newport Beach, San Jose, and Torrance. Member FDIC
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.